The IAS–USA Guidelines Panel Recommendation on the Use of Cabotegravir and Rilpivirine

In a letter to JAMA published today, March 1, the IAS–USA Guidelines Panel provided its HIV treatment recommendation on the use of cabotegravir and rilpivirine. To learn more about this most recent update, click here.